Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
10 /100
COMPONENT-LIMITED
Score updated Sep 12, 2026

HQY — HealthEquity, Inc. Dilution Risk Tracker

Track HQY dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track HQY — Get alerts when the score changes →

As of September 12, 2026, HealthEquity, Inc. (HQY) has a DilutionWatch DilutionScore of 10/100, rated LOW dilution risk. This is a component-limited score because one or more material inputs are unavailable or not applicable. HealthEquity, Inc. has a market capitalization of $7.36B, 82.72M shares outstanding, 490 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
19
💰Cash Runway
📊 Float Risk
5
⚠️ Warrant Exposure
15
🔄 Convertible Debt
15

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for HQY.
🔔 Track HQY — Get forecast alerts →

Market Data

Market Cap$7.36B
Shares Outstanding82.72M
Float81.95M
Cash$256.00M
Debt$931.06M
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore10/100DilutionWatch score record
Shares Outstanding82.72MVerified float table or market cache
Public Float81.95MVerified float table or market cache
Market Cap$7.36BMarket data cache
Cash RunwayNot applicable / unavailableDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 6.

Recent SEC source mix: 4 5, XBRL 1.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 7.2% shares (2026Q1 vs prior)
490 institutional holders · 97.88M shares
#1 BlackRock, Inc. 10.53M shares
#2 VANGUARD CAPITAL MANAGEMENT LLC 7.65M shares
#3 WASATCH ADVISORS LP 7.20M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest4.52M
Days to Cover4.3
% of Float5.5%
FINRA data as of Aug 31, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2015-01-31
4 INSIDER TRANSACTION 2026-04-08
4 INSIDER TRANSACTION 2026-04-08
4 INSIDER TRANSACTION 2026-04-08
4 INSIDER TRANSACTION 2026-04-08
Full SEC filing analysis available with free account

Recent News

No recent news

Factual HQY Dilution Snapshot

HealthEquity, Inc. (HQY) has a DilutionScore of 10/100, rated Low dilution risk. Score date: September 12, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track HQY Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking HQY — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — LOW Risk

Other LOW dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 8,348+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations

Score Coverage Note

More Research for HQY
HQY FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.